Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
|
|
CUMBERLAND PHARMACEUTICALS INC (CPIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.71, valued at
$111.2
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 10/03/2023 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.72, valued at
$111.8
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 10/03/2023 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 280 shares
@ $2.03, valued at
$568.4
Small acquisition of 280 shares
@ $2.12, valued at
$593.6
Small acquisition of 280 shares
@ $2.14, valued at
$599.2
Small acquisition of 280 shares
@ $2.28, valued at
$638.4
Small acquisition of 280 shares
@ $2.29, valued at
$641.2
Small acquisition of 280 shares
@ $2.24, valued at
$627.2
Small acquisition of 280 shares
@ $2.07, valued at
$579.6
Small acquisition of 280 shares
@ $1.98, valued at
$554.4
Small acquisition of 280 shares
@ $1.96, valued at
$548.8
Small acquisition of 280 shares
@ $1.9, valued at
$532 |
|
| 10/03/2023 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.71, valued at
$111.2
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| JACOBS JOEY A (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Disposed of 5,000 shares
@ $2.75, valued at
$13.8k
|
|
| 03/21/2023 |
4
| KAZIMI A J (Chairman and CEO) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 37,205 shares
@ $1.92, valued at
$71.4k
|
|
| 03/21/2023 |
4
| Herman James L (VP and Chief Compliance Office) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,280 shares
@ $1.92, valued at
$2.5k
|
|
| 03/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/23/2022 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 20 shares
@ $2.33, valued at
$46.6
Bought 20 shares
@ $2.31, valued at
$46.2
Bought 20 shares
@ $2.19, valued at
$43.8
Bought 20 shares
@ $2.19, valued at
$43.8
Bought 20 shares
@ $2.18, valued at
$43.6
Bought 20 shares
@ $2.19, valued at
$43.8
Bought 20 shares
@ $2.15, valued at
$43
Bought 20 shares
@ $2.14, valued at
$42.8
Bought 20 shares
@ $2.18, valued at
$43.6
Bought 20 shares
@ $2.21, valued at
$44.2
Bought 20 shares
@ $2.24, valued at
$44.8 |
|
| 12/23/2022 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 31 shares
@ $2.33, valued at
$72.2
Bought 31 shares
@ $2.31, valued at
$71.6
Bought 31 shares
@ $2.19, valued at
$67.9
Bought 31 shares
@ $2.19, valued at
$67.9
Bought 31 shares
@ $2.18, valued at
$67.6
Bought 31 shares
@ $2.19, valued at
$67.9
Bought 31 shares
@ $2.15, valued at
$66.7
Bought 31 shares
@ $2.14, valued at
$66.3
Bought 40 shares
@ $2.18, valued at
$87.2
Bought 40 shares
@ $2.21, valued at
$88.4
Bought 20 shares
@ $2.24, valued at
$44.8 |
|
| 12/23/2022 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 65 shares
@ $2.33, valued at
$151.5
Bought 65 shares
@ $2.31, valued at
$150.2
Bought 65 shares
@ $2.19, valued at
$142.4
Bought 65 shares
@ $2.19, valued at
$142.4
Bought 65 shares
@ $2.18, valued at
$141.7
Bought 65 shares
@ $2.19, valued at
$142.4
Bought 65 shares
@ $2.15, valued at
$139.8
Bought 65 shares
@ $2.14, valued at
$139.1
Bought 120 shares
@ $2.18, valued at
$261.6
Bought 120 shares
@ $2.21, valued at
$265.2
Bought 60 shares
@ $2.24, valued at
$134.4 |
|
| 12/23/2022 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 105 shares
@ $2.33, valued at
$244.7
Bought 105 shares
@ $2.31, valued at
$242.6
Bought 105 shares
@ $2.19, valued at
$230
Bought 105 shares
@ $2.19, valued at
$230
Bought 105 shares
@ $2.18, valued at
$228.9
Bought 105 shares
@ $2.19, valued at
$230
Bought 105 shares
@ $2.15, valued at
$225.8
Bought 105 shares
@ $2.14, valued at
$224.7
Bought 320 shares
@ $2.18, valued at
$697.6
Bought 320 shares
@ $2.21, valued at
$707.2
Bought 144 shares
@ $2.24, valued at
$322.6 |
|
| 12/23/2022 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 20 shares
@ $2.53, valued at
$50.6
Bought 20 shares
@ $2.54, valued at
$50.8
Bought 20 shares
@ $2.44, valued at
$48.8
Bought 20 shares
@ $2.42, valued at
$48.4
Bought 20 shares
@ $2.45, valued at
$49
Bought 20 shares
@ $2.42, valued at
$48.4
Bought 20 shares
@ $2.37, valued at
$47.4
Bought 20 shares
@ $2.37, valued at
$47.4
Bought 20 shares
@ $2.32, valued at
$46.4
Bought 20 shares
@ $2.32, valued at
$46.4
Bought 20 shares
@ $2.35, valued at
$47 |
|
| 12/23/2022 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 31 shares
@ $2.53, valued at
$78.4
Bought 31 shares
@ $2.54, valued at
$78.7
Bought 31 shares
@ $2.44, valued at
$75.6
Bought 31 shares
@ $2.42, valued at
$75
Bought 31 shares
@ $2.45, valued at
$76
Bought 31 shares
@ $2.42, valued at
$75
Bought 31 shares
@ $2.37, valued at
$73.5
Bought 31 shares
@ $2.37, valued at
$73.5
Bought 31 shares
@ $2.32, valued at
$71.9
Bought 31 shares
@ $2.32, valued at
$71.9
Bought 31 shares
@ $2.35, valued at
$72.9 |
|
| 12/23/2022 |
4
| Galante Joseph C (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 65 shares
@ $2.53, valued at
$164.5
Bought 65 shares
@ $2.54, valued at
$165.1
Bought 65 shares
@ $2.44, valued at
$158.6
Bought 65 shares
@ $2.42, valued at
$157.3
Bought 65 shares
@ $2.45, valued at
$159.3
Bought 65 shares
@ $2.42, valued at
$157.3
Bought 65 shares
@ $2.37, valued at
$154.1
Bought 65 shares
@ $2.37, valued at
$154.1
Bought 65 shares
@ $2.32, valued at
$150.8
Bought 65 shares
@ $2.32, valued at
$150.8
Bought 65 shares
@ $2.35, valued at
$152.8 |
|
| 12/23/2022 |
4
| Krogulski Kenneth (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 105 shares
@ $2.53, valued at
$265.7
Bought 105 shares
@ $2.54, valued at
$266.7
Bought 105 shares
@ $2.44, valued at
$256.2
Bought 105 shares
@ $2.42, valued at
$254.1
Bought 105 shares
@ $2.45, valued at
$257.3
Bought 105 shares
@ $2.42, valued at
$254.1
Bought 105 shares
@ $2.37, valued at
$248.9
Bought 105 shares
@ $2.37, valued at
$248.9
Bought 105 shares
@ $2.32, valued at
$243.6
Bought 105 shares
@ $2.32, valued at
$243.6
Bought 105 shares
@ $2.35, valued at
$246.8 |
|
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|